港股開盤 | 恆生科指低開1.2%,科技股繼續下跌
香港恆生指數4月8日(週五)開盤下跌141.45點,跌幅0.65%,報21667.53點;國企指數4月8日(週五)開盤下跌62.05點,跌幅0.83%,報7433.49點;紅籌指數4月8日(週五)開盤下跌5.36點,跌幅0.13%,報4028.87點。
大型科技股持續走低,美團跌超3%,阿裏巴巴、百度、京東跌超2%,騰訊跌超1%;互聯網醫療股大跌居前,體育用品股、乳製品股、保險股、生物科技股多數下跌,藥明生物跌3.3%,布油跌穿100美元關口,石油股齊跌。另一方面,重型機械股表現較佳,中國中鐵、中國鐵建皆上漲。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.